Introduction
The most common cause of renovascular hypertension in patients presenting under 40 years of age, fibromuscular dysplasia (FMD), is three times more common in females than males. 1 Suggested pathophysiological factors have included mechanical arterial stretching, 2 female sex hormones, 3, 4 genetic factors, 5, 6 vascular spasm, 7 defects in arterial elastic tissue 3 and smoking. [8] [9] [10] [11] There has been much interest in the role of polymorphisms of the renin-angiotensin (RA) system, not only in hypertension but in cardiovascular disease in general. Angiotensin II (Ang II), an octapeptide hormone, is the main effector peptide of RA system. 12, 13 Angiotensinogen (AGT), synthesised in the liver, is cleaved by renin to form the decapeptide, quencies did not differ significantly between groups, except that MF-FMD patients had a significantly higher frequency of the ACE I allele than control subjects (0.62 vs 0.47, P ‫؍‬ 0.026). Since the ACE I allele is associated with lower circulating ACE levels and possibly lower tissue levels of angiotensin II (Ang II), and since Ang II modulates vascular smooth muscle cell growth and synthetic activity, the I allele might predispose to defective remodelling of the arterial media, and thus to the development of MF-FMD. This contrasts with atherosclerotic renal artery stenosis, coronary stent restenosis and carotid intimal thickening, which are diseases affecting the arterial intima, and which are associated with increased frequency of the D allele. Journal of Human Hypertension (2001) 15, [185] [186] [187] [188] [189] [190] angiotensin I (Ang I), which is then cleaved by angiotensin converting enzyme (ACE) to form Ang II. 14 Ang II is not only a powerful vasoconstrictor, but also modulates vascular smooth muscle cell (VSMC) growth and synthetic activity. 15, 16 These latter effects are markedly suppressed or abolished by Ang II type 1 receptor (AT 1 R) antagonism. 15, 16 Studies suggest that neointimal hyperplasia following arterial injury can be significantly reduced by ACE inhibition [17] [18] [19] [20] and by selective AT 1 R blockade.
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Hence, not only is the RA system important in hypertension directly by vasoconstriction and VSMC growth, but also in failure of interventions which increase the arterial lumen but damage the vessel wall. Thus the RA system affects the behaviour of the lining as well as the muscular wall of arteries, and these effects may be achieved by quite different mechanisms. The RA system has the capacity to influence predominantly endothelial pathology, such as atherosclerosis, but also hypertrophy of the muscular arterial wall, as in some forms of FMD. 1, 22 As well, Ang II is the principal regulator of aldosterone levels, and aldosterone has a trophic effect on myocardial cells and the VSMC, as well as promoting fibrosis. [23] [24] [25] [26] Polymorphisms associated with differing levels of Ang II are therefore of interest in FMD.
An increased prevalence of the ACE D allele has been reported in patients with atherosclerotic renal artery stenosis when compared with controls. 27 While the atherosclerotic process is very different histologically and, probably, aetiologically, from FMD, both are examples of vascular occlusive disease, and perhaps the components of the RA system might also modulate the development of FMD.
Circulating levels of the enzyme renin and its substrate AGT are important determinants of circulating Ang I and, after conversion of Ang I to Ang II by ACE, of Ang II levels. In general, the higher the level of AGT, the higher the level of Ang II. Certain polymorphisms of the AGT gene are associated with higher AGT levels. 28 The ACE D allele is associated with higher circulating levels of ACE 29 which, other things being equal, will also be associated with higher circulating levels of Ang II. Increased ACE activity and the ACE D allele have both been associated with an increase in carotid intimal-medial thickness, the distance between the media-adventitia interface and the lumen-intima interface, 30 in both diabetic 31 and non-diabetic [32] [33] [34] subjects. Coronary stent restenosis, which is primarily a result of neointimal hyperplasia, 35 was significantly increased in patients with the ACE DD genotype. 36, 37 On the other hand, restenosis following coronary angioplasty without stent, which appears to be primarily due to vessel remodelling, 38 was not associated with ACE genotype. [39] [40] [41] Percutaneous transluminal renal angioplasty (PTRA) has become the treatment of first choice for renal artery FMD. Therefore, current diagnosis and classification of FMD is based on the angiographic rather than histologic appearance. 6, 9, 42 Lesions are classified as multifocal FMD (MF-FMD), in which there are multiple points of stenosis within the one lesion, and unifocal FMD (UF-FMD) in which there is a single short or elongated stenosis.
Typical microaneurysmal MF-FMD is usually associated with medial fibroplasia on histological examination. 1, 22, 43 This pattern usually affects the mid-to distal portions of the renal artery and is usually right-sided or bilateral. 1, 6, 22, 44 Other arteries, particularly the internal carotid and external iliac arteries, may be affected. 1, 6 Approximately 90% of patients with medial fibroplasia are females between 25 and 50 years of age. 1, 6, 22, 44, 45 UF-FMD usually affects the proximal segments of the renal artery. This pattern is characteristic of intimal fibroplasia. However, all histological FMD subtypes may produce unifocal lesions. 46 In UF-FMD, the left and right renal arteries are affected with similar frequency and bilateral involvement is less common. Patients with UF-FMD tend to be younger than those with MF-FMD, and do not display the female predominance seen in MF-FMD.
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Exploring a possible role for the RA system in the development of FMD, we examined polymorphisms of the ACE, AT 1 R and AGT genes in 43 patients with angiographically typical MF-FMD and in 89 control subjects.
Methods and materials
A total of 110 hypertensive patients referred between 1970 and 1997 were diagnosed with FMD of the renal arteries. Angiograms of 66 patients were available for review by at least two of the authors. Typical microaneurysmal MF-FMD was identified in 43 subjects.
Eighty-nine normotensive volunteers ('controls') were recruited from staff of the Greenslopes Private Hospital and the University of Queensland Departments of Medicine and Surgery. Subjects were included as controls if they met the following criteria: (1) able to provide informed consent, (2) no personal history of hypertension nor cardiovascular disease, (3) had never taken antihypertensive medications, (4) no family history of FMD or early (aged Ͻ50) cardiovascular events, and (5) normal blood pressure, defined as a seated blood pressure reading of р140/90 mm Hg (average of two seated blood pressure readings taken approximately 2 min apart).
Venous blood was collected from each subject into lithium heparin tubes and stored at −70°C until DNA extraction. DNA was extracted from whole blood using a commercial kit (Nucleon BACC2; Amersham International, Little Chalfont, Buckinghamshire, UK).
The ACE I/D polymorphism was identified by polymerase chain reaction using the primers described by Lindpaintner et al 47 (hace3s 5ЈGCCCTGCAGGTGTCTGCAGCATGT3Ј; hace3as 5ЈGGATGGCTCTCCCCGCCTTGTCTC3Ј). Preferential amplification of the D allele occurs in ID heterozygotes, leading to misclassification of ID as DD in 4% to 5% of cases. 47 Therefore, all DD samples were subjected to a second, separate PCR amplification with a primer pair which recognises the insertionspecific sequence (hace5a, 5ЈTGGGACCACAGCG CCCGCCACTAC3Ј; hace5c, 5ЈTCGCCAGCCCTCCC ATGCCCATAA3Ј). 47 Reactions were performed in a final volume of 20 l containing 1 M sense primer, 1 M antisense primer, 200 M dNTPs (Promega, Madison, WI, USA), 0.35 U Taq DNA polymerase with 2 l of the supplied PCR reaction buffer (QIAGEN, Clifton Hill, Victoria, Australia), 4 l QSolution (QIAGEN, Clifton Hill, Victoria, Australia) and 1 l genomic DNA. Q-Solution is a non-DMSO solution which 'facilitates amplification of difficult templates by modifying the melting behavior of DNA' (QIAGEN Product Guide 1999). Thermocycling was performed for 35 cycles with denaturation at 94°C for 30 sec, annealing for 45 sec (at 56°C for the hace3 primers and 69°C for the hace5 primers), and extension at 72°C for 2 min with a final extension at 72°C for 7 min. The amplified products were electrophoresed on 1% agarose gels, stained with ethidium bromide and viewed under UV illumination. The hace3 primers resulted in 319-bp and 597-bp amplicons, representing, respectively, the D and I alleles. The hace5 primers resulted in a 335-bp fragment produced only in the presence of the I allele.
Determination of the ATR A1166C polymorphism is facilitated by the presence in the C allele of an additional recognition site for the restriction endonuclease Dde I. 48 Amplification using the primers 5Ј-AATGCTTGTAGCCAAAGTCACCT-3Ј and 5Ј-GGCTTTGCTTTGTCTTGTTG-3Ј results in an 856-bp product. 49 Subsequent digestion with DdeI produces two bands of 602-bp and 254-bp for the A allele, with the C allele having two smaller bands (143-bp and 111-bp) in place of the 254-bp band. The PCR reaction mixture was the same as for the ACE I/D polymorphism. DNA was amplified for 40 cycles with denaturation at 94°C for 1 min, annealing at 60°C for 1 min, and extension at 72°C for 2 min with a final extension at 72°C for 10 mins. The amplified PCR product was subjected to digestion with DdeI (New England BioLabs, Beverly, MA, USA). Each 15 l digestion contained 8 l PCR product, 5 U DdeI and 1.5 l of the supplied buffer. Digestion was performed at 37°C for 2 hours. The resulting digestion product was electrophoresed on 2% agarose gels, stained with ethidium bromide and viewed under UV illumination.
Determination of the AGT T174M and M235T polymorphisms was performed according to the method of Rutledge et al. 50 A single pair of primers is used to amplify a 338-bp fragment of DNA containing the two polymorphisms:
sense 5Ј-GATGCGCACAAGGTCCTGTC-3Ј, antisense 5Ј-CCGCCCGCCCCGCCCGCCGCCCGCC CCGCCCGCCGCCCGC TGCTGTCCACACTGGCT CGC-3Ј. The antisense primer includes a 40-bp GC-clamp to ensure visualisation of the fragments after digestion. The T174M mutation involves a C→T base substitution, introducing an Nco I restriction site (CٙCATGG) in the 174 M allele. The M235T mutation involves a T→C base substitution. The mispairing primer method creates a BstU I restriction site (CGٙCG) in the presence of the 235T allele. The PCR reaction mixture was the same as for the ACE I/D polymorphism. DNA was amplified for 40 cycles with denaturation at 94°C for 30 sec, annealing at 64°C for 30 sec, and extension at 72°C for 2 min with a final extension at 72°C for 10 min. To detect the T174M polymorphism, 8 l of PCR product was digested with 10 U Nco I at 37°C for 2 hours. To detect the M235T polymorphism, 8 l of PCR product was digested 10 U BstU I at 60°C for 2 hours. The resulting digestion products were electrophoresed on 2% agarose gels, stained with ethidium bromide and viewed under UV illumination.
Statistical analysis was performed using Statistica for Windows (Release 5.0) (StatSoft Inc, Tulsa, OklaJournal of Human Hypertension homa, USA). Parametric data was compared using the t-test for independent samples. The Fisher exact test was used to compare allele frequencies between groups. A two-sided probability value of Ͻ0.05 was considered significant.
Results
Demographic and clinical characteristics of the 43 MF-FMD subjects and the 89 control subjects are presented in Table 1 . At the time of diagnosis of FMD, subjects with MF-FMD were significantly older than controls (47.7 ± 10.9 years vs 35.5 ± 10.3 years, P Ͻ 0.0001). However, there was no difference in the ages of the MF-FMD group at the time of diagnosis of hypertension and controls (38.6 ± 11.1 years vs 35.5 ± 10.3 years, P = 0.12). Both groups had a similar proportion of females (95% vs 86%, P = 0.14).
Histological diagnoses were available for five subjects: three with unilateral right-sided MF-FMD and two with bilateral MF-FMD. Each of the five subjects had a histological diagnosis of medial fibroplasia.
Genotype distributions and allele frequencies for the ACE I/D, AT 1 R A1166C, AGT T174M and AGT M235T polymorphisms are presented in Table 2 . The frequency of the ACE I allele was significantly higher in the MF-FMD group than in controls (0.62 vs 0.47, P = 0.026). No significant differences were 47.7 ± 10.9 Age at diagnosis of 38.6 ± 11.6 35.5 ± 10.3 0.12 hypertension or normotension (years) Females (%) 41 (95%) 77 (86%) 0.14 a Values expressed as n or mean ± s.d. The age given for the control subjects is the age at recruitment into the study. 
Discussion
Major difficulties in any study of FMD are: (1) the necessity of classification by angiographic appearance since success of PTRA reduces the availability of tissue for histological, histochemical or genetic examination, and (2) the imperfect correlation between angiographic and histological diagnoses. Yet accurate phenotypic determination is essential for meaningful genetic analysis. In this study we have attempted to define a group of subjects with angiographic appearances absolutely typical of medial fibroplasia by selecting subjects with typical microaneurysmal MF-FMD. In the current study, angiographic diagnosis of MF-FMD accurately predicted the histological diagnosis of medial fibroplasia in the five subjects where this was available.
The fibromuscular ridges of MF-FMD are characterised by degeneration of medial elastic fibres and replacement of the normal media by loose collagen and plump disoriented smooth muscle cells. 22 The mural aneurysms between these fibromuscular ridges consist of thinning or loss of smooth muscle with deficiency of the IEL. 22 This is in contrast to the other pathological forms of FMD, with either extensive fibroplasia of the outer half of the media in 'subadventitial fibroplasia' or the intimal changes of intimal fibroplasia. 22 It is also in marked contrast to the pathology of atherosclerosis and stent restenosis.
In the current study, patients with MF-FMD had a significantly higher frequency of the ACE I allele than controls. The increased prevalence of the ACE I allele in MF-FMD is in contrast of studies of coronary stent restenosis, 36, 37 carotid intimal thickening, [32] [33] [34] and atherosclerotic renal artery stenosis 27 in each of which an association between increased risk and the ACE D allele has been reported, and to a large prospective study seeking an association between ACE genotypes and the risk of ischaemic heart disease or myocardial infarction 47 in which no association was found with either allele. This is not surprising, given that MF-FMD has a completely different morphological lesion from that of atheromatous disease.
The ACE I allele is associated with lower circulating ACE levels than the ACE D allele. 29 Muller et al, 51 using perfused isolated rat hindquarters in rats with and without two-kidney one clip (2K1C) hypertension, showed that increased ACE gene expression and ACE levels led to an increase in conversion of Ang I to Ang II. Therefore, the ACE I allele is probably associated with lower local concentrations of Ang II. Could the ACE I allele, by an association with lower local concentrations of Ang II, impede remodelling, and thus promote the development of MF-FMD? Perhaps we should not be looking for a genotype which predisposes to intimal hyperplasia but a genotype which predisposes to defective remodelling in the muscular layer of arteries.
While MF-FMD is principally a disease of females of reproductive age, 1, 22 atherosclerotic arterial disease tends to spare this group. The gender-associated predisposition to MF-FMD has not been explained. However, female sex hormones have been proposed as possible pathogenic factors. 1 In oophorectomised rats, chronic administration of estrogens was associated with lower plasma and tissue ACE activities by approximately 40%, compared to oophorectomised animals without estrogen replacement. 52, 53 In similar studies in cynomolgus monkeys 54 oestrogen replacement reduced plasma ACE activity by 17%. Furthermore, a significant reduction in ACE mRNA was demonstrated in lung, aorta, renal cortex and renal medulla in estradioltreated oophorectomised rats. 52 Reduction of serum ACE activity has also been reported in the first and second trimesters in normotensive pregnant females with elevated plasma oestrogen compared to nonpregnant controls, 55 and following combined oestradiol valerate/norethisterone hormone replacement therapy for 6 months in healthy normotensive postmenopausal females. 56 Therefore, by the mechanism of lowered tissue Ang II, the combined effects of estrogens and the ACE I allele may predispose to the development of MF-FMD, particularly in females of reproductive age.
While FMD and atherosclerotic arterial stenosis are very different diseases, it is of interest that smoking, which has a marked effect on the development and progression of atheroma, is also associated with an increased severity of MF-FMD. 8 Just as severe atheroma can occur in non-smokers, smoking is not essential for the development of FMD. 8 To the best of our knowledge, this is the first report investigating the relationship between the polymorphisms of the RA system and FMD. In view of the paucity of knowledge regarding the aetiology and pathogenesis of FMD, the possible effects of differing levels of activity of the renin-angiotensin system on the development of FMD deserve further investigation.
